Refreshing results…
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Download from doi.orgPhase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
Download from doi.orgData from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
UploadElevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
Download from doi.orgA COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Download from www.nature.comPhase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell Immunity
UploadPreexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
UploadPre-existing and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients
UploadSARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition
UploadMissing publications? Search for publications with a matching author name.